Acute disseminated encephalomyelitis, commonly called ADEM, is a sudden inflammatory attack on the brain and spinal cord that damages the protective coating around nerve fibers. It usually strikes days to weeks after a viral infection or, far less often, after a vaccination. Children are the most common patients, and the illness typically hits once and then resolves, though it can leave subtle traces and, in a minority of cases, come back. Because ADEM can look alarming at the outset and mimic other serious neurological conditions, understanding what it is, how it behaves, and what to expect from recovery matters both for patients and their families.
What Happens in the Brain During ADEM
ADEM is an autoimmune condition in which the immune system turns on myelin, the insulating sheath that wraps nerve fibers in the brain and spinal cord. When myelin is damaged, nerve signals slow down or misfire, which explains the wide range of neurological symptoms ADEM can produce. The damage shows up as scattered patches of inflammation in the brain’s white matter, and in some cases the spinal cord and optic nerves as well.
The immune system’s mistake likely arises through a process called molecular mimicry: proteins on a recently encountered virus happen to look similar enough to myelin proteins that immune cells trained to fight the infection also attack the brain’s own tissue. Other contributing pathways have been proposed, including bystander activation (where general immune inflammation in the area accidentally harms nearby myelin) and epitope spreading (where the initial damage exposes new myelin fragments that draw further immune attention).1Infection and Autoimmunity. Pathophysiology of Acute Disseminated Encephalomyelitis – Immune and Autoimmune Aspects Research on brain tissue from ADEM patients has found inflammatory chemicals known to be toxic to myelin, supporting the idea that the immune response itself causes the neural damage.2PubMed. In situ cytokine immune responses in acute disseminated encephalomyelitis: insights into pathophysiologic mechanisms
Under the microscope, the hallmark finding is demyelination clustered around small veins in the brain, a pattern called perivenous demyelination. That pattern is one of the clearest ways pathologists can distinguish ADEM tissue from the confluent plaques seen in multiple sclerosis.3Brain. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis
Common Triggers
Most ADEM cases follow an identifiable trigger. Roughly three-quarters of cases are linked to a preceding infection or, less commonly, a vaccination.4PubMed Central. Post-vaccination encephalomyelitis: literature review and illustrative case The remaining cases arise without a clear preceding illness, sometimes called “spontaneous” ADEM.
On the infectious side, a wide variety of viruses and some bacteria have been documented as triggers. Upper respiratory infections are among the most common culprits, but measles, Epstein-Barr virus, cytomegalovirus, herpes simplex, and many others have all been linked. The onset of neurological symptoms typically appears one to three weeks after the fever or infection resolves, which is part of what makes the autoimmune explanation compelling: the immune response has had time to build up and go awry.5JAMA Neurology. Acute Disseminated Encephalomyelitis: An Update
Post-vaccination ADEM is far rarer but has been documented after vaccines for rabies, measles, mumps, rubella, hepatitis B, influenza, Japanese encephalitis, pertussis, and others.6PubMed Central. Post-vaccination encephalomyelitis: literature review and illustrative case It is worth keeping this in perspective: data consistently show that the rate of ADEM and other neurological complications is substantially higher after natural infections than after vaccination against those same infections.7PubMed Central. Pediatric Acute Disseminated Encephalomyelitis Triggered by Concurrent Administration of Seasonal and H1N1 Influenza Vaccines: A Case Report and Review In other words, the vaccine reduces the very risk it is occasionally blamed for.
Who Gets ADEM
ADEM predominantly affects children, with peak incidence in childhood years. Adults can develop it too, but the disease tends to behave differently depending on age. In adults, hospitalization is typically longer, intensive-care admission is more frequent, and full motor recovery after the first episode is less likely. Mortality, while low overall, is also higher in adults: one comparative study reported a death rate of about 12% in adults versus 1% in children.8PubMed. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children The reasons for this age gap are not fully understood, but it may relate to differences in immune maturity and the brain’s capacity for repair.
The condition is rare in absolute terms, though exact incidence figures vary across studies. Boys and men appear to be affected slightly more often than girls and women, though the reasons for this are unclear.
Symptoms and What the Acute Phase Looks Like
ADEM comes on quickly. Over a few days, a previously healthy person, often a child recovering from a cold or flu, develops neurological symptoms that can be alarming. The defining clinical feature is encephalopathy, meaning an altered level of consciousness. This can range from confusion and excessive sleepiness to severe lethargy or even coma. Because ADEM causes scattered inflammation across the brain, the specific neurological deficits depend on which areas are hit.
Common symptoms include:
- Motor problems: weakness on one or both sides of the body, trouble walking, or unsteady coordination
- Vision changes: blurred or double vision, or complete vision loss if the optic nerves are involved
- Speech difficulties: slurred speech or trouble finding words
- Seizures: more frequent in children than adults
- Headache and vomiting: often the earliest complaints, sometimes mistaken for a lingering viral illness
The combination of encephalopathy and multiple neurological deficits appearing together is what clinically defines ADEM.9PubMed. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome 10PubMed Central. Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient This multifocal pattern, affecting several parts of the nervous system at once, is what separates ADEM from a stroke or a brain abscess, which tend to affect a single area.
How ADEM Is Diagnosed
There is no single blood test that confirms ADEM. The diagnosis rests on a combination of the clinical picture, brain imaging, and ruling out other explanations for acute encephalopathy.11PubMed Central. Acute disseminated encephalomyelitis
MRI is the most important diagnostic tool. It typically shows widespread white-matter lesions that are bright on certain sequences, reflecting areas of inflammation and demyelination. These lesions are often large and poorly defined, sometimes involving the deep gray matter structures like the thalamus and basal ganglia, which is a pattern more suggestive of ADEM than of multiple sclerosis.
A lumbar puncture (spinal tap) is usually performed to examine the cerebrospinal fluid. Results are highly variable: about one in five adult patients have completely normal spinal fluid findings. When abnormalities are present, they may include elevated white blood cell counts or elevated protein. One finding with particular diagnostic weight is oligoclonal bands, which are markers of immune activity in the spinal fluid. These were found in about 65% of adult ADEM patients in one follow-up study, which creates a diagnostic wrinkle since oligoclonal bands are also a hallmark of multiple sclerosis.12PubMed. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients
Telling ADEM Apart from Multiple Sclerosis
The overlap between ADEM and multiple sclerosis is one of the most challenging problems in neurology, especially at the initial presentation. Both conditions involve immune-mediated demyelination. Both can produce similar-looking lesions on MRI. Both can cause a wide range of neurological symptoms. At the first episode, the two conditions cannot be distinguished with certainty, and prolonged follow-up is often needed to establish the correct diagnosis.13PubMed Central. Acute disseminated encephalomyelitis in children: differential diagnosis from multiple sclerosis on the basis of clinical course
Several features tip the balance toward ADEM: the presence of encephalopathy (which is unusual in MS relapses), younger age, a clear preceding infection, bilateral and large brain lesions rather than the smaller ovoid lesions that favor MS, and involvement of the deep gray matter. But none of these are absolute, and doctors often have to wait and watch. If the patient has another demyelinating episode months or years later, especially one with a different pattern from the first, the diagnosis may shift toward MS.
This diagnostic uncertainty is stressful for families, and it is one reason why follow-up MRI scans and clinical assessments over months to years are standard practice after an ADEM diagnosis.
The Role of MOG Antibodies
One of the most useful advances in sorting out ADEM and its look-alikes has been the discovery of antibodies against myelin oligodendrocyte glycoprotein, known as MOG antibodies or MOG-IgG. These antibodies target a protein on the surface of the cells that make myelin. Testing for them has changed how clinicians think about ADEM and its prognosis.
MOG antibodies are found in a majority of children with ADEM. In one large study of 210 children with various demyelinating conditions, MOG antibodies were present in 57% of those diagnosed with ADEM, compared to just 8% of those later diagnosed with MS.14PubMed. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome Higher MOG antibody levels at onset were linked to younger age and to the ADEM diagnosis itself.
Where MOG antibodies become particularly interesting is in predicting what happens next. Children who remain persistently positive for MOG antibodies over time appear to be at higher risk for relapse. In one study, nearly 9 out of 10 children with persistent MOG positivity experienced at least one relapse over a median follow-up of about six years.15JAMA Neurology. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders These relapses often took the form of optic neuritis or further brain inflammation rather than a simple repeat of the initial ADEM episode.
Conversely, very high MOG antibody levels at onset predicted a non-MS course with high specificity, essentially helping to reassure families that their child was unlikely to develop multiple sclerosis, even if further non-MS episodes occurred.16PubMed. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome This distinction matters enormously, because the treatment approach and long-term outlook for MOG-associated disease and MS are quite different.
Treatment
Because ADEM is driven by an overactive immune response, treatment focuses on suppressing that response. The standard first-line therapy is high-dose intravenous corticosteroids, typically methylprednisolone given for three to five days, followed by a gradual oral steroid taper over four to six weeks.17PubMed. Treatment of acute disseminated encephalomyelitis Most patients improve substantially with this approach, though the speed of recovery varies. Some children bounce back within days, while others take weeks to regain function.
When steroids are not enough, the next step is usually intravenous immunoglobulin (IVIG), a blood product that helps modulate the immune system. For patients who remain resistant to both steroids and IVIG, plasma exchange (plasmapheresis) is an option. This procedure physically removes circulating antibodies and inflammatory molecules from the blood. Case reports and small series have described full neurological recovery in steroid-resistant patients after plasma exchange.18Transfusion Medicine and Hemotherapy. Role of Plasma Exchange in a Steroid- and IVIG-Refractory Patient with Acute Disseminated Encephalomyelitis: A Case Report
The tapering phase of steroids is considered important: cutting them too quickly has been associated with rebound inflammation. Most specialists follow a gradual reduction over several weeks rather than stopping abruptly after the IV course.
Monophasic Versus Relapsing ADEM
ADEM has traditionally been described as a one-time event, and for the majority of patients that holds true. But about a quarter of patients experience at least one relapse. In one large retrospective study of 228 patients across multiple US centers, 24% had at least one further episode.19PubMed. Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study
When relapses occur, they may be classified differently depending on the pattern. If the new episode affects the same brain regions as the first, it may be called “recurrent” ADEM. If it involves new areas, the term “multiphasic” ADEM is used.20PubMed Central. Acute disseminated encephalomyelitis In children, relapses were more often classified as multiphasic ADEM, while in adults, relapses were more frequently reclassified as MS.21PubMed. Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study
The discovery of MOG antibodies (discussed above) has reframed some of what was previously called “multiphasic ADEM” as MOG antibody-associated disease, a condition now increasingly recognized as its own diagnostic entity rather than a subtype of ADEM or MS. For families, the practical takeaway is that a relapse after ADEM does not automatically mean MS; the MOG antibody picture and the clinical pattern both matter in determining the correct diagnosis.
Long-Term Outlook and Lingering Effects
For most children, the long-term prognosis after monophasic ADEM is encouraging. Group-average IQ scores and overall quality of life tend to fall within normal ranges at follow-up. But averages can mask individual difficulties. In one study, about 23% of children who had recovered from monophasic ADEM showed impairments in specific cognitive functions, with attention being the area most frequently affected.22Pediatric Neurology. Neurocognitive Outcome and Quality of Life in Pediatric Monophasic Acute Disseminated Encephalomyelitis Interestingly, children evaluated further out from the acute event did better than those evaluated sooner, suggesting that cognitive recovery may continue for years. This contrasts with MS, where cognitive function tends to decline over time, and it underscores the distinct nature of ADEM.
A broader review of outcome studies found persistent difficulties with attention and information-processing speed, along with elevated rates of depression and anxiety, even in patients whose MRI scans had normalized.23PubMed Central. Cognitive and psychopathological outcomes in acute disseminated encephalomyelitis The disconnect between a clean-looking MRI and ongoing cognitive symptoms is a point of frustration for many families. It suggests that standard imaging does not capture all the subtle neural damage that ADEM may leave behind.
For adults, the picture is somewhat less optimistic. As noted earlier, adults are less likely to achieve complete motor recovery, and the acute phase carries higher morbidity. Long-term cognitive data in adults is thinner than in children, partly because adult ADEM is rarer and harder to study in large numbers.24PubMed Central. Clinical comparative analysis of monophasic and multiphasic acute disseminated encephalomyelitis in adults
Acute Hemorrhagic Leukoencephalitis
At the far end of the severity spectrum sits a rare variant sometimes called Hurst disease or acute hemorrhagic leukoencephalitis (AHLE). It is considered the most severe form of ADEM, marked by explosive onset, widespread hemorrhagic inflammation in the brain’s white matter, and a high mortality rate.25PubMed Central. Acute Hemorrhagic Leukoencephalitis (AHLE): A Comprehensive Review on Causes, Symptoms, Link with COVID-19, Diagnosis, and Treatment Patients can go from healthy to deeply comatose within hours or days. MRI typically shows massive brain swelling with areas of bleeding, a much more dramatic picture than standard ADEM.
One published case involved a 25-year-old woman who developed complete paralysis of all four limbs and lost consciousness within two days of an upper respiratory tract infection. Her MRI showed extensive brainstem involvement with hemorrhagic foci.26PubMed Central. Weston-Hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (ADEM) Cases like this require immediate aggressive treatment, often including high-dose steroids, plasma exchange, and intensive care support. Even with aggressive therapy, outcomes are poor in many cases, and survivors frequently have substantial neurological deficits.
AHLE is exceedingly rare. Its inclusion in the ADEM family reflects the shared suspected mechanism of post-infectious autoimmune demyelination, but the clinical experience is so different that clinicians generally treat it as a distinct emergency rather than simply a “bad case” of ADEM.
Living with the Aftermath
For families navigating recovery from ADEM, a few practical realities are worth knowing. First, the MRI will often look worse than the child feels. Large, dramatic-looking brain lesions at diagnosis can shrink substantially or even disappear over months, and functional recovery often outpaces what the images would predict. Second, fatigue is a common complaint during recovery, sometimes lasting months after the acute illness resolves. This is not unusual after any significant brain inflammation and generally improves with time, though the pace is unpredictable.
Third, schools and workplaces may need to make accommodations. Attention difficulties and slower information processing are the most commonly reported lingering cognitive issues, and they are not always obvious on standard neurological exams. Neuropsychological testing, rather than a standard office visit, is the best way to identify and document these subtle deficits so that appropriate support can be arranged.
Fourth, follow-up matters. Because the initial diagnosis can be uncertain and some patients eventually turn out to have MS or MOG-associated disease, repeat MRIs and clinical assessments at intervals are standard practice. If new symptoms develop months or years later, families should not assume it is a benign recurrence; prompt reassessment is warranted to determine whether the diagnosis has changed and whether different treatment is needed.